Follow up study on LC of PEGASYS/COPEGUS in Phase II/III

Follow up study on LC of PEGASYS/COPEGUS in Phase II/III - Follow up study on LC of PEGASYS/COPEGUS in Phase II/III

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008052

Enrollment

149

Registered

2012-05-29

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C with compensated liver cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were included in Phase II/III (JV19595 and JV19889) are able to follow up

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
developing HCC rate and advance of decompensatory cirrhosis rate	—

Countries

Japan

Contacts

Public ContactAyaka Shimizu

Chugai Pharmaceutical Co., Ltd. Real World Data Science Dept.

shimizuayk@chugai-pharm.co.jp03-3273-0905

Outcome results